Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Jeffs Roger, Chief Executive Officer. Director active across 3 companies, notably Liquidia Corp. Aggregated, 59 filings have been published. Breakdown: 5 buys · 20 sells. Total volume traded: €17.2m. History available since 19 November 2021. The latest transaction was disclosed on 13 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Jeffs Roger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
JEFFS ROGER is Directeur Général and has 55 filings in total. In the 55 most recent filings available, between 2016-01-05 and 2026-06-11, buys amount to EUR 1391605 and sells to EUR 13573507, with the modal transaction nature listed as Sale. He is associated with Liquidia Corp, UNITED THERAPEUTICS Corp and Axsome Therapeutics, Inc.